“Are HFOT & NIV Complementary for Acute Respiratory Failure?”
Saxe Communications & Philips* present…“Are HFOT & NIV Complementary for Acute Respiratory Failure?”
With the widespread utilization of noninvasive ventilation (NIV) for the treatment of respiratory failure, as well as the increasing utilization of humidified high flow oxygen therapy (HFOT) for the treatment of various forms of respiratory compromise, clinicians now have a broader range of noninvasive tools aimed at managing acute respiratory failure. However, the precise indication of each one of these therapies is still a question of debate. This webinar is intended to provide a more detailed comparative understanding of the clinical application of NIV, HFOT and Conventional Oxygen Therapy (COT), to show differences and similarities in modes of action, and to analyze the scientific evidence on the clinical benefits when these technologies are compared.
Learning Objectives | At the end of this session, participants should be able to:
- Discuss the physiological effects of HFOT for its clinical application in ARF.
- Discuss the evidence for the use of HFOT in ARF.
- Describe the comparative effects and outcomes of HFOT, NIV and COT in ARF
F. Javier Belda, M.D., Ph.D. | Professor of Anesthesiology & Critical Care | Department of Surgery | Faculty of Medicine & Odontology | University of Valencia. Spain
Continuing Education: 1.0 contact hour for Respiratory & Nurses
- Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care, 9425 N. MacArthur Blvd. Suite 100, Irving, TX 75063
- Provider (Saxe Healthcare Communications) approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032
Educational support provided by Philips
Questions should be directed to: Producer@WebinarCreativeTechnology.com
* NOTE: This is a supplier and industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service drug, brand or approach.”